Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B
about
Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling TechniquesCost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United StatesPrevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data.Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantationLower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire.Markov modeling in hepatitis B screening and linkage to careA simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effectiveShould patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.Barriers to screening for hepatitis B virus infection in Asian Americans.Knowledge, Awareness and Medical Practice of Asian Americans/Pacific Islanders on Chronic Hepatitis B Infection: Review of Current Psychosocial EvidenceThe increasing burden of imported chronic hepatitis B--United States, 1974-2008.Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.Community-based hepatitis B screening: what works?Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.Too much of a good thing? When to stop catch-up vaccinationInfection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.Hepatitis B prevention and control: Lessons from the East and the WestAgent-based models and systems science approaches to public healthA comparison of effectiveness of hepatitis B screening and linkage to care among foreign-born populations in clinical and nonclinical settings.The cost-effectiveness of screening for chronic hepatitis B infection in the United States.Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis.Hepatitis C transmission and treatment in contact networks of people who inject drugs.Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions.Evidence-based clinical guidelines for immigrants and refugees.Cost-effective control of chronic viral diseases: finding the optimal level of screening and contact tracing.Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.Medical training fails to prepare providers to care for patients with chronic hepatitis B infection.Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?Cost of treating chronic hepatitis B: comparison of current treatment guidelines.Improving the identification of priority populations to increase hepatitis B testing rates, 2012.New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysisInfluence of information sources on hepatitis B screening behavior and relevant psychosocial factors among Asian immigrants.Hepatitis B screening and vaccination practices in asian american primary care.Disease burden of chronic hepatitis B among immigrants in Canada.Hepatitis B virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population?
P2860
Q26774500-9C87131A-C0DE-400C-A01C-1E4ED7752A9CQ28488762-4FABDB99-56C1-402F-8A00-68041C6406EDQ30634658-2EEC8F39-BB4E-4FF9-998D-6E593A0733FEQ30861975-C1CE7A35-8030-46C3-9C24-5BA6A9BB5EFBQ33405646-0E5505E5-0FC0-4D05-91D6-1B9B5480B6CFQ33678323-B61F381C-FC0E-470A-B890-E2BECE1B2B53Q33706787-E9B26741-7074-434F-9A8E-C7DD049BFC27Q33804151-6130DF4D-6CEC-41E5-984C-C02D72CA6DF9Q33836312-24AD1839-B0B8-4EA1-83BA-62A46270DFF6Q34000950-BE0385DE-9389-429E-B8B7-98DDDF91F9EAQ34069878-1E0D5C88-27E1-44BB-B115-82CC8EF9C089Q34098106-21EE92EE-B059-4A94-9AA8-3B686AAF8A09Q34098870-6D041CEE-CA7E-4D18-B159-ACAD880B419BQ34137291-69FC18E6-A373-4846-AB03-04B4049B8912Q34260638-B19636EC-D8AE-4AA7-8F69-77959FCBBF83Q34277699-3BB3F711-5697-4FED-9358-692B0A8EB3FCQ34408236-897B361A-426D-4954-86F3-969C173F387CQ34585496-0255EC25-71DD-4B87-9330-E2E615FF12B2Q34677180-2E649061-D41C-4233-8305-CA5028CF9056Q34695171-ED54828A-276F-45F2-8FA6-1FD9ECD65655Q34703748-F07941DE-A77D-4A34-84D8-B5CE68A3172DQ34954194-42558558-2414-4B90-BE32-899A3027C409Q34990604-8148C9DD-8788-4DEA-8C21-A20AC7E6701EQ35036504-1982BDA2-9BB9-4668-A7C9-B220BCEAC6DEQ35040866-13546E10-C728-4D43-9F0A-977AD621B105Q35099170-6944329C-C0EE-4ACC-927E-C82B1AEC41BCQ35201293-D0B6CD65-D2B6-46B5-895C-813AB792BED0Q35605667-5FCE1EEF-844A-4C7C-84C0-F8958FB8DB4EQ35632910-CB7E345B-2248-4407-BF23-2223A93976FAQ35716226-DC8AC8FF-9D3A-40B7-B88B-B224A877958CQ36129764-9CD31E2B-6E3B-446A-8DC6-F31902D47C1BQ36179464-6536D93A-2119-48DB-B9EB-549DCFF73A86Q36250930-6ED03340-5D26-4376-A56B-2AA680F4929CQ36395368-F73A815D-8D9C-45DF-B3C0-CC5B3F612A53Q36528950-8EE4DD5F-5789-4B74-A856-1A312497FDADQ36652084-8FDABB78-1D45-41F0-92A6-C777F0D6C818Q36736155-57451785-47C7-4A1F-AE12-834154DEF897Q37046567-C725B050-A167-4CFD-8FBE-3868EB96D087Q37066397-F7983916-A224-4153-95BF-48CF66C56906Q37163549-96F580EE-D390-49A1-A578-9DF60FF75834
P2860
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@ast
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@en
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@nl
type
label
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@ast
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@en
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@nl
prefLabel
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@ast
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@en
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@nl
P2093
P3181
P1476
Cost-effectiveness of screenin ...... slander adults for hepatitis B
@en
P2093
Daniel Tan
David W Hutton
Margaret L Brandeau
Samuel K So
P3181
P356
10.7326/0003-4819-147-7-200710020-00004
P407
P577
2007-10-02T00:00:00Z